NeOnc Technologies is the developer of a novel molecular technology that provides enhanced targeted delivery of therapeutics for the treatment of CNS-based diseases.
NeOnc’s delivery technology has resulted in a wide array of combinatorial formulations that are designed to take gold-standard CNS disease therapeutics and enhance their effectiveness and ability to cure while reducing both cost and patient side effects.
Optimizing The Bridge Between Delivery and Cure
NeOnc Technologies has developed a three-prong solution to advancing the delivery
of Pharma-therapeutics to the brain to effect a better potential for cure then is currently available.
Neontech’s development and research into their novel therapeutic delivery technology has already shown great promise in a variety of applications. The following studies show the impressive foundational work that the company has accomplished in validating the efficacy and importance of their product.